# Changzhou Pharmaceutical Factory, Changzhou, China – FDA Inspections

Source: https://www.keypedia.com/companies/changzhou-pharmaceutical-factory/eea165e1-3df2-47c8-94b9-e8400af46bc4

> Inspection records and compliance data for Changzhou Pharmaceutical Factory in Changzhou. 7 FDA inspections on record, 1 Form 483, last inspected January 12, 2024.

---

## Details

- Name: Changzhou Pharmaceutical Factory
- FEI Number: 3002806661
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE
- Address Line 1: No. 518 Laodong East Rd
- City: Changzhou
- Country Name: China
- Address: No. 518 Laodong East Rd, Changzhou, China
- Country: China

## Related Documents

- [483 - Changzhou Pharmaceutical Factory - 2024-01-12](https://www.keypedia.com/records/483/changzhou-pharmaceutical-factory/cd894f30-d17f-4d2d-b9f2-85a72e934cea) — source: FDA, date: January 12, 2024
- FDA Inspection 1228229 - Changzhou Pharmaceutical Factory - 2024-01-12 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 12, 2024
- [FDA Inspection 1081510 - Changzhou Pharmaceutical Factory - 2019-01-25](https://www.keypedia.com/records/fda_inspections/changzhou-pharmaceutical-factory/61910488-3446-4cae-829a-eb41443fd620) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 25, 2019
- FDA Inspection 1020837 - Changzhou Pharmaceutical Factory - 2017-06-23 — classification: No Action Indicated (NAI), source: FDA, date: June 23, 2017
- FDA Inspection 973109 - Changzhou Pharmaceutical Factory - 2016-05-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 20, 2016
- FDA Inspection 973109 - Changzhou Pharmaceutical Factory - 2016-05-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 20, 2016
- FDA Inspection 929673 - Changzhou Pharmaceutical Factory - 2015-05-01 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 1, 2015
- FDA Inspection 797914 - Changzhou Pharmaceutical Factory - 2012-08-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 9, 2012
- FDA Inspection 573945 - Changzhou Pharmaceutical Factory - 2009-04-02 — classification: No Action Indicated (NAI), source: FDA, date: April 2, 2009

## Related Companies

- [Boehringer Ingelheim Pharma GmbH & Co. KG](https://www.keypedia.com/companies/boehringer-ingelheim-pharma-gmbh-co-kg/bcb705bf-98ed-451f-a79d-b6223d2ed263)
- [Cohance Lifesciences Limited](https://www.keypedia.com/companies/cohance-lifesciences-limited/c01306bf-33dc-4f28-a424-11cda764a0d5)
- [Xellia Pharmaceuticals ApS](https://www.keypedia.com/companies/xellia-pharmaceuticals-aps/5d9704ca-114e-4a65-abca-966a5c4e2a57)
- [Excella GmbH & Co. KG](https://www.keypedia.com/companies/excella-gmbh-co-kg/82bb94ef-8b2e-4e51-8c40-b71a184257f1)
- [Sumitomo Dainippon Pharma Co., Ltd.](https://www.keypedia.com/companies/sumitomo-dainippon-pharma-co-ltd/40ead027-5fd5-4deb-a37b-40301cffd612)
- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/ca77117b-0afe-4b51-bdc2-82ee1e242ec8)
- [Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany](https://www.keypedia.com/companies/halo-pharmaceutical-inc-dba-cambrex-whippany/1464443d-ae5a-4d06-959c-d1ccb1b213a2)
- [IDT Australia Ltd.](https://www.keypedia.com/companies/idt-australia-ltd/efc89096-ddbd-47cd-be83-bfa50b1bed16)
- [A. Nelson & Co., Ltd.](https://www.keypedia.com/companies/a-nelson-co-ltd/36fe9f82-7169-47d2-9e57-8ed77942c73d)
- [Amgen, Inc.](https://www.keypedia.com/companies/amgen-inc/85ec512e-6991-42ee-9cd5-148cfe0ed3e8)

## Related Officers

- [Investigator](https://www.keypedia.com/people/amy-n-chen/c3515e0e-dbb9-4540-bd2b-82c06d00dd42)
- [Consumer Safety Officer](https://www.keypedia.com/people/rajiv-r-srivastava/05b42bfd-0cf4-42ce-89e1-b81bf36eaa17)
